ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

The Cloning Story: How Dolly Made Page 1 And A Physicist Got Air Time

May 15, 1998

In Brief: Wittes To Become Acting DCT Director; Kaufman Leaves NCI For Private Practice

February 17, 1995

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994